AAAAAA

   
Results: 1-3 |
Results: 3
PHENYLIMIDAZOLIDIN-2-ONE DERIVATIVES AS SELECTIVE 5-HT3 RECEPTOR ANTAGONISTS AND REFINEMENT OF THE PHARMACOPHORE MODEL FOR 5-HT3 RECEPTOR-BINDING
Authors: HEIDEMPERGHER F PILLAN A PINCIROLI V VAGHI F ARRIGONI C BOLIS G CACCIA C DHO L MCARTHUR R VARASI M
Citation: F. Heidempergher et al., PHENYLIMIDAZOLIDIN-2-ONE DERIVATIVES AS SELECTIVE 5-HT3 RECEPTOR ANTAGONISTS AND REFINEMENT OF THE PHARMACOPHORE MODEL FOR 5-HT3 RECEPTOR-BINDING, Journal of medicinal chemistry, 40(21), 1997, pp. 3369-3380
ERGOLINE DERIVATES AS A PROBE FOR FEATURING THE 5-HT1A RECEPTOR PHARMACOPHORE
Authors: BOLIS G PILLAN A MANTEGANI S BRAMBILLA E DOLMELLA A
Citation: G. Bolis et al., ERGOLINE DERIVATES AS A PROBE FOR FEATURING THE 5-HT1A RECEPTOR PHARMACOPHORE, JOURNAL OF MOLECULAR MODELING, 1(4), 1995, pp. 188-195
AGENTS COMBINING THROMBOXANE RECEPTOR ANTAGONISM WITH THROMBOXANE SYNTHASE INHIBITION - [[[2-(1H-IMIDAZOL-1-YL)ETHYLIDENE]AMINO]OXY] ALKANOIC ACIDS
Authors: COZZI P GIORDANI A MENICHINCHERI M PILLAN A PINCIROLI V ROSSI A TONANI R VOLPI D TAMBURIN M FERRARIO R FUSAR D SALVATI P
Citation: P. Cozzi et al., AGENTS COMBINING THROMBOXANE RECEPTOR ANTAGONISM WITH THROMBOXANE SYNTHASE INHIBITION - [[[2-(1H-IMIDAZOL-1-YL)ETHYLIDENE]AMINO]OXY] ALKANOIC ACIDS, Journal of medicinal chemistry, 37(21), 1994, pp. 3588-3604
Risultati: 1-3 |